En español
NIDA

Indiana Opioid Summary

Revised February 2018

Opioid-Related Overdose Deaths

In 2016, there were 794 opioid-related overdose deaths­­­ in Indiana—a rate of 12.6 deaths per 100,000 persons compared to the national rate of 13.3 deaths per 100,000 persons. A large increase in heroin-related overdose deaths occurred from 2012 to 2016—from 114 to 297 deaths. Deaths related to synthetic opioids also increased in the same period from 43 to 304 deaths.

This graph shows the rate of opioid-related overdose deaths in Indiana compared to the United States from 1999-2016. In 2016, the opioid overdose death rate was 12.6 deaths per 100,000 persons in Indiana, versus 13.3 deaths per 100,000 persons in the United States.

Opioid Pain Reliever Prescriptions

In 2015, Indiana providers wrote 109.1 opioid prescriptions per 100 persons (approximately 5.8 million prescriptions). (IMS Health, 2016).  

This graph shows the number of opioid-related overdose deaths in Indiana from 1999-2016. In 2016, there were 794 opioid-related overdose deaths: 304 involved synthetic opioids, 297 involved heroin, and 262 involved prescription opioids. Categories are not mutually exclusive because deaths may involve more than one drug.

Neonatal Abstinence Syndrome (NAS)

A CDC study analyzing 2013 NAS data available across 28 states estimated the national average NAS rate at 0.6 percent of live births (CDC, MMWR, 2014). Data for NAS rates in Indiana are unavailable.

HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)

  • U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
  • U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
  • State Incidence: Of the new HIV cases in 2015, 632 occurred in Indiana, with 7.6 percent1 of new cases in males and 5.6 percent of new cases in females attributed to IDU (AIDSVu).
  • State Prevalence: In 2014, an estimated 10,279 persons were living with a diagnosed HIV infection in Indiana—a rate of 188 cases per 100,000 persons. Of these, 14.0 percent1 of males and 15.9 percent of females were living with HIV attributed to IDU (AIDSVu).  

Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use

  • U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
  • U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
  • State Incidence: In 2015, Indiana reported 7,004 cases of chronic HCV and 140 cases of acute HCV—a total of 7,144 cases at a rate of 107.9 cases per 100,000 persons. Where data were available, 30 percent reported IDU. 8.6 percent of persons with HIV are co‐infected with HCV, and of these, 34 percent reported injection drug use. In contrast, 97.1 percent of co-infected cases reported in the 2014 Scott County outbreak were attributed to injection drug use (IN.gov).
  • State Prevalence: As of 2015, an estimated 81,538 persons were living with HCV in Indiana (IN.gov).

Additional Resources

NIH RePORTER FY2017 NIH-funded projects related to opioid use and use disorder in Indiana: 3

Notes

  1. Includes transmission to individuals with injection drug use as a risk factor.
  2. 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.

This page was last updated February 2018

Get this Publication

Opioid Summaries by State

NIH HEAL (Helping to End Addiction Long-term) Initiative

New Opioid Overdose Materials for Patients

Easy-to-read Drug Facts

This Is NIDA: Opioids

This Is NIDA: Opioids

The National Institute on Drug Abuse's research-based, informative video series "This Is NIDA," addresses the topic of OPIOIDS.